Analyses Find Patients With Polycythemia Vera (PV) Treated With BESREMi® (ropeginterferon alfa-2b) Had Increased Probability of Achieving Complete Hematologic Response
Crwe World,
Analyses published in the British Journal of Clinical Pharmacology suggest a favorable balance between benefits and risks…